Attention deficit-hyperactivity disorder. Disturbance of activity and attention
Conditions
Interventions
Intervention 1: Intervention group will receive 50 mg/kg/day of L-carnitine syrup (product of shahr Darou company which contains 1g/10cc of drug)
in divided dose,BID,morning and afternoon except takin
Treatment - Drugs
Placebo
Intervention group will receive 50 mg/kg/day of L-carnitine syrup (product of shahr Darou company which contains 1g/10cc of drug)
in divided dose,BID,morning and afternoon except taking Methylphenida
Control group will receive 50 mg/kg/day of placebo ( Sucrose solution in the same package and same dilution asL-carnitine syrup)BID,morning and afternoon except taking their Methylphenidate tablet.
Sponsors
Vice chancellor for Research Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 16 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:Age 6-16; Diagnosis of ADHD for the first time Exclusion criteria : IQ<70 ; Having other chronic medical illnesses; Be under other medications; Any serious or sever complication during study; Refusal of child or parent to continue the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Attention, Impulsivity & Behavioral indecies. Timepoint: At the begining,3 weeks later & 6 weeks later. Method of measurement: Conner's parents questionaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Child's general function. Timepoint: At the begining of study , 3 weeks later , 6 weeks later. Method of measurement: CGAS questionare.;Drug complication. Timepoint: 3 weeks after begining of the study & 6 weeks later. Method of measurement: Rachell & klein Side effects Form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Fateme Noori
Tehran Institute of Psychiatry
Outcome results
None listed